Loading clinical trials...
Loading clinical trials...
Phase 2 Clinical Platform Trial Investigating Multiple Therapeutic Options for the Treatment of Hospitalized Patients With Acute Respiratory Distress Syndrome (ARDS)
Conditions
Interventions
Cohort A: vilobelimab
Cohort A: placebo
+4 more
Locations
36
United States
University of Alabama Hospital
Birmingham, Alabama, United States
Community Regional Medical Center
Fresno, California, United States
Long Beach Memorial Medical Center
Long Beach, California, United States
University of California Irvine Medical Center
Orange, California, United States
University of California Davis Medical Center - Pulmonary Medicine
Sacramento, California, United States
Denver Health Hospital and Authority
Denver, Colorado, United States
Start Date
June 10, 2025
Primary Completion Date
July 1, 2028
Completion Date
September 1, 2028
Last Updated
March 25, 2026
NCT04068012
NCT07504731
NCT07123961
NCT07414056
NCT06701669
NCT07246837
Lead Sponsor
PPD Development, LP
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions